STOCK TITAN

Synchrony Financial (SYF) Form 4 Filings

SYF NYSE

Here are the Form 4 insider transactions from Synchrony Financial (SYF) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SYF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SYF filings page.

Rhea-AI Summary

Synchrony Financial director Kamila K. Chytil reported an automatic award of dividend equivalent units. On February 17, 2026, she acquired 14 dividend equivalent units at an indicated price of $72.31 per unit, bringing her directly held balance to 16,232 units. These units were accrued as dividends on common shares underlying restricted stock units and will vest, settle, and expire on the same terms as the related restricted stock units. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

Rhea-AI Summary

MOTHNER JONATHAN S reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial executive Jonathan S. Mothner received additional stock-based compensation through dividend equivalent units. On February 17, 2026, he was granted 233 dividend equivalent units tied to dividends paid on common shares underlying his restricted stock units, at a reference price of $72.31 per share. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock. Following this grant, Mothner directly holds 161,290 units/shares in total.

Rhea-AI Summary

Synchrony Financial officer Bart Schaller reported both an equity award and a share sale. On February 17, 2026, he acquired 175 dividend equivalent units tied to existing restricted stock units, each economically equal to one share of Synchrony common stock and vesting on the same schedule.

On the same date, he sold 35,300 shares of Synchrony common stock in an open-market transaction at $70.60 per share under a pre-arranged Rule 10b5-1 trading plan adopted on October 29, 2025. Following these transactions, he directly held 77,600 dividend equivalent units and 42,300 common shares.

Rhea-AI Summary

Synchrony Financial director Arthur W. Coviello Jr reported an automatic acquisition of 14 dividend equivalent units on February 17, 2026. These units were accrued as dividends on common shares underlying his restricted stock units, at a reference value of $72.31 per unit. After this grant, his directly held dividend equivalent and related units total 32,458 units. Each dividend equivalent unit is economically equal to one share of Synchrony Financial common stock and will vest, settle, and expire on the same terms as the related restricted stock units.

Rhea-AI Summary

Synchrony Financial director Laurel Richie reported an automatic award of dividend equivalent units linked to existing equity awards. On February 17, 2026, Richie acquired 129 dividend equivalent units at a reference price of $72.3100 per unit.

The units were accrued as dividends on common shares underlying restricted stock units and deferred stock units previously granted under Synchrony’s long-term incentive and non-employee director deferred compensation plans. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock, bringing Richie’s directly held total to 49,884 units after the transaction.

Rhea-AI Summary

Synchrony Financial director Alves Paget Leonard reported an automatic grant of dividend equivalent units. On February 17, 2026, Leonard acquired 147 dividend equivalent units tied to previously granted restricted stock units and deferred stock units under Synchrony’s long-term incentive and non-employee director deferred compensation plans at a reference price of $72.31 per unit.

Each dividend equivalent unit represents the economic value of one share of Synchrony Financial common stock, and Leonard’s holdings in these related units increased to 50,558 following this accrual.

Rhea-AI Summary

Synchrony Financial director Fernando Aguirre reported an automatic acquisition of dividend equivalent units tied to his restricted stock units. On February 17, 2026, he received 14 dividend equivalent units, each economically equal to one share of Synchrony Financial common stock, reflecting dividends paid on the underlying RSUs. His directly held dividend equivalent and related non-derivative holdings now total 28,576 units/shares. He also reports indirect ownership of 15,300 common shares held by family trusts.

Rhea-AI Summary

Synchrony Financial executive Curtis Howse reported an automatic grant of dividend equivalent units. On the dividend payment date, he acquired 208 dividend equivalent units tied to existing restricted stock units, each economically equivalent to one share of Synchrony Financial common stock and vesting on the same schedule as the underlying awards.

Rhea-AI Summary

Synchrony Financial officer receives additional stock-linked units through dividends. On February 17, 2026, Brian J. Wenzel Sr. acquired 287 dividend equivalent units tied to existing restricted stock units, bringing his directly held units and related common stock equivalents to 116,569.

The dividend equivalent units were accrued as dividends on common shares underlying restricted stock units and will vest, settle, and expire on the same terms as those restricted stock units. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

Rhea-AI Summary

DOUBLES BRIAN D reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director and officer Brian D. Doubles reported an automatic award of 1,172 dividend equivalent units on February 17, 2026. These units were credited as dividends on common shares underlying his restricted stock units at a reference value of $72.31 per unit and increase his directly held derivative-equivalent position to 942,058 units. The dividend equivalent units will vest, settle, and expire on the same schedule and terms as the related restricted stock units and are each economically equivalent to one share of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial officer Darrell Owens reported mixed insider activity. On February 17, 2026, he sold 10,304 shares of common stock in an open-market transaction at $70.60 per share, under a Rule 10b5-1 trading plan adopted on October 17, 2025.

On the same date, he acquired 68 dividend equivalent units at $72.31 per unit, tied to underlying restricted stock units and economically equivalent to common shares. Following these transactions, he directly held 16,233 shares of common stock and 26,537 dividend equivalent units.

Rhea-AI Summary

GUTHRIE ROY A reported acquisition or exercise transactions in this Form 4 filing.

Synchrony Financial director Roy A. Guthrie reported an award of 146 dividend equivalent units on February 17, 2026. These units reflect dividends paid on common shares underlying restricted stock units and deferred stock units previously granted under the company’s long-term incentive and non-employee director deferred compensation plans.

Each dividend equivalent unit is economically equal to one share of Synchrony Financial common stock, bringing Guthrie’s directly held derivative balance to 38,880 units after the award. The filing also notes 34,106 common shares held indirectly by Guthrie 2012 Investments LP, for which Guthrie disclaims beneficial ownership except for his direct pecuniary interest.

Rhea-AI Summary

Synchrony Financial executive Amy Tiliakos reported an automatic award of dividend equivalent units linked to existing restricted stock units. On the transaction date, she acquired 59 dividend equivalent units at a reference price of $72.31 per unit, bringing her directly held units to 17,994.

The footnote explains these dividend equivalent units were accrued as dividends paid on the common shares underlying her restricted stock units. They will vest, settle, and expire on the same schedule and terms as the related restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial director Parker P.W. reported an automatic grant related to existing equity awards. On February 17, 2026, Parker acquired 14 dividend equivalent units at a reference price of $72.31 per unit, bringing direct holdings to 32,789 units. These dividend equivalent units were credited as cash dividends were paid on common shares underlying restricted stock units, and they will vest and settle on the same schedule and terms as those restricted stock units. Each unit is economically equal to one share of Synchrony Financial common stock, but follows the vesting and expiration conditions of the related awards.

Rhea-AI Summary

Synchrony Financial executive Curtis Howse reported an automatic stock sale under a pre-set trading plan. On February 2, 2026, he sold 52,556 shares of Synchrony Financial common stock at $72.32 per share in an open-market sale coded "S."

The filing notes this transaction was made under a Rule 10b5-1 trading plan adopted on July 24, 2025, indicating it was pre-arranged. After the sale, Howse directly owned 94,196 shares of Synchrony Financial common stock and is identified as EVP, CEO--Home & Auto.

Rhea-AI Summary

Synchrony Financial director Arthur W. Coviello Jr. reported selling 4,000 shares of Synchrony Financial common stock on February 2, 2026. The shares were sold at a price of $72.32 per share in an open-market transaction.

After this sale, Coviello beneficially owns 32,444 shares of Synchrony common stock in direct form. The transaction was carried out under a pre-established Rule 10b5-1 trading plan that he adopted on July 25, 2025, indicating the sales were scheduled in advance rather than decided at the last minute.

Rhea-AI Summary

Synchrony Financial President and CEO Brian D. Doubles, who also serves as a director, reported equity award activity in company stock. On January 21, 2026, he acquired 390,751 shares of common stock at $77.13 per share in connection with the vesting of Performance Share Units under the 2023–2025 Long-Term Performance Program, based on pre-established performance goals for that period.

On the same date, 181,132 shares of common stock at $77.13 per share were withheld by Synchrony Financial to cover his tax liability related to that PSU vesting. After these transactions, Doubles beneficially owned 940,886 shares of Synchrony Financial common stock directly.

Rhea-AI Summary

Synchrony Financial executive Curtis Howse reported equity compensation activity in company stock. On January 21, 2026, he acquired 67,590 shares of Synchrony Financial common stock at $77.13 per share, earned through the vesting of Performance Share Units under the 2023–2025 Long-Term Performance Program based on pre-set performance goals. On the same date, 29,322 shares were withheld by the company, also at $77.13 per share, to cover his tax obligations from this vesting. After these transactions, Howse directly held 146,752 shares of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial executive Courtney Gentleman reported equity compensation activity tied to performance share units. On January 21, 2026, Gentleman acquired 18,313 shares of Synchrony Financial common stock at $77.13 per share, earned upon vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-established performance goals. On the same date, 6,267 shares were withheld by the company at $77.13 per share to cover the related tax liability. Following these transactions, Gentleman directly owned 29,824 shares of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial executive Bart Schaller, EVP and CEO–Digital, reported equity compensation activity involving the company’s common stock. On January 21, 2026, he acquired 58,939 shares of Synchrony Financial common stock at $77.13 per share. These shares were earned upon the vesting of Performance Share Units granted under the company’s 2023–2025 Long-Term Performance Program, based on pre-established performance goals for that period.

On the same date, 23,638 shares were withheld by Synchrony Financial at a price of $77.13 per share to cover Schaller’s tax obligations related to the PSU vesting. After these transactions, Schaller directly owned 77,425 shares of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial executive stock activity: Executive Vice President and Chief Financial Officer Brian J. Wenzel reported equity-related transactions in Synchrony Financial common stock on January 21, 2026. He acquired 87,957 shares of common stock at $77.13 per share, earned through the vesting of Performance Share Units under the Company’s 2023–2025 Long-Term Performance Program based on pre-established performance goals for that period. On the same date, 40,845 shares were withheld by Synchrony Financial at $77.13 per share to cover his tax obligations arising from this vesting. Following these transactions, Wenzel directly owned 116,282 shares of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial executive Darrell Owens reported equity compensation activity involving company common stock. On January 21, 2026, he acquired 15,213 shares of Synchrony Financial common stock at $77.13 per share, earned upon vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-established performance goals.

The company withheld 4,909 shares at $77.13 per share to cover Owens’ tax liability related to the PSU vesting. After these transactions, Owens directly held 26,469 shares of Synchrony Financial common stock in his capacity as EVP & CEO--Lifestyle.

Rhea-AI Summary

Synchrony Financial executive Jonathan S. Mothner, EVP and Chief Risk and Legal Officer, reported stock transactions tied to long-term incentives. On January 21, 2026, he acquired 63,444 shares of Synchrony common stock at $77.13 per share, earned through the vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-set performance goals. On the same date, 29,487 shares were withheld by the company at the same price to cover his tax obligations from this vesting. After these transactions, he directly owned 161,057 shares of Synchrony common stock.

Rhea-AI Summary

Synchrony Financial EVP Alberto Casellas reported equity compensation activity involving company common stock. On January 21, 2026, he acquired 67,590 shares of Synchrony Financial common stock at $77.13 per share, earned through the vesting of Performance Share Units under the 2023–2025 Long-Term Performance Program based on pre-established performance goals.

On the same date, 31,870 shares were withheld by the company at $77.13 per share to cover his tax liability from the PSU vesting. After these transactions, Casellas directly owned 92,850 shares of Synchrony Financial common stock in his capacity as EVP, CEO–Health & Wellness.

Rhea-AI Summary

Synchrony Financial executive equity award activity: EVP, Chief Technology and Operating Officer Carol Juel reported stock transactions tied to long-term incentive compensation. On 01/21/2026, she acquired 79,305 shares of Synchrony common stock, earned upon vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-established performance goals. On the same date, 34,894 shares were withheld by the company to cover her tax liability related to this vesting. After these transactions, she held 102,941 shares of Synchrony common stock directly.

Rhea-AI Summary

Synchrony Financial reported that one of its directors received a new equity grant in the form of restricted stock units. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock at a price of $83.43 per share, increasing the director’s beneficial ownership to 32,775 shares held directly after the transaction.

The award is structured as restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock, meaning the director must satisfy the vesting conditions before receiving the underlying shares.

Rhea-AI Summary

Synchrony Financial reported an equity award to one of its directors. On 12/31/2025, the director acquired 660 shares of Synchrony Financial common stock at a price of $83.43 per share, reported as an acquisition of common stock. An accompanying note explains that this represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of common stock at vesting. After this transaction, the director beneficially owned 28,562 shares directly and 15,300 shares indirectly through family trusts.

Rhea-AI Summary

Synchrony Financial director reports equity award in Form 4 filing. A board member received 660 shares of Synchrony Financial common stock on December 31, 2025 at a price of $83.43 per share, reported as an acquisition. After this transaction, the director beneficially owns 49,755 shares directly.

The award is in the form of restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock, so the director’s actual share ownership will increase as these units vest.

Rhea-AI Summary

Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. After this transaction, the director beneficially owns 3,972 shares of common stock directly.

The 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock. This filing reflects a routine director equity grant rather than an open-market stock purchase or sale.

Rhea-AI Summary

Synchrony Financial director reported receiving a grant of restricted stock units. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. Following this transaction, the director beneficially owns 660 shares directly. The filing notes that these restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of common stock.

Rhea-AI Summary

Synchrony Financial director reports new stock award. A company director filed details of a stock-based compensation grant involving Synchrony Financial common stock. On 12/31/2025, the director acquired 660 shares in the form of restricted stock units at a value of $83.43 per share. After this grant, the director beneficially owns 16,218 shares of Synchrony Financial common stock in direct ownership.

The filing notes that these 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial director reports stock grant

A director of Synchrony Financial reported acquiring 660 shares of common stock on December 31, 2025 at a price of $83.43 per share, as shown in a Form 4 filing. Following this transaction, the director beneficially owns 50,411 shares of Synchrony Financial common stock in direct ownership.

The filing explains that this grant represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock at vesting. This reflects routine equity-based compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Synchrony Financial director reports stock-based award and holdings

A Synchrony Financial director reported receiving 660 shares of common stock as a stock-based award on 12/31/2025 at a price of $83.43 per share. These are in the form of restricted stock units that will vest in full on December 31, 2026, with each unit representing a contingent right to receive one share of Synchrony Financial common stock.

Following this grant, the director beneficially owns 38,734 shares directly and 34,106 shares indirectly through Guthrie 2012 Investments LP, where he is the investment manager and disclaims beneficial ownership except for his direct pecuniary interest.

Rhea-AI Summary

Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 1,035 shares of Synchrony Financial common stock at a price of $83.43 per share, recorded as an acquisition of non-derivative securities. After this transaction, the director beneficially owned 62,487 shares of Synchrony Financial common stock in direct form.

The filing explains that this grant represents restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit gives the director a contingent right to receive one share of Synchrony Financial common stock once the vesting date is reached, aligning director compensation with the company’s share performance.

Rhea-AI Summary

Synchrony Financial director reports stock-based compensation grant. A board member of Synchrony Financial received 660 shares of common stock on December 31, 2025 at a price of $83.43 per share, reported as an acquisition of non-derivative securities. Following this transaction, the director beneficially owns 36,444 shares of Synchrony Financial common stock in direct ownership.

The grant represents restricted stock units that will vest in full on December 31, 2026, with each unit convertible into one share of Synchrony Financial common stock. This filing reflects routine equity compensation for a director rather than an open-market purchase or sale.

Rhea-AI Summary

Synchrony Financial reported that one of its directors acquired additional equity through a stock-based award. On December 31, 2025, the director received 660 shares of common stock, shown at a price of $83.43 per share, bringing the director’s directly held beneficial ownership to 30,529 shares after the transaction.

An explanation clarifies that this award represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock when vested. This filing reflects routine director compensation in the form of equity rather than an open-market purchase or sale.

Rhea-AI Summary

Synchrony Financial (SYF) reported an insider equity accrual for its EVP and CFO on a Form 4. On 11/17/2025, the officer received 294 dividend equivalent units tied to restricted stock units, reflecting dividends paid on the underlying common shares at a reference price of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock.

After this transaction, the reporting person beneficially owned 69,170 common shares or related units on a direct basis.

Rhea-AI Summary

Synchrony Financial filed a Form 4 reporting a routine equity-related transaction by an officer who serves as SVP, Chief Accounting Officer and Controller. On 11/17/2025, the officer received 61 dividend equivalent units at a value of $70.47 per unit, credited as dividends on common shares underlying restricted stock units. After this transaction, the officer beneficially owned 17,935 non-derivative securities directly. The dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is the economic equivalent of one share of Synchrony Financial common stock.

Rhea-AI Summary

Synchrony Financial (SYF) reported a Form 4 filing showing a director acquired additional equity-linked units through routine compensation. On November 17, 2025, the director received 15 dividend equivalent units tied to previously granted restricted stock units, at a reference price of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the director beneficially owns 32,115 common shares on a direct basis.

Rhea-AI Summary

Synchrony Financial (SYF) executive reports dividend-related equity awards. On 11/17/2025, an officer serving as EVP, CEO–Health & Wellness reported receiving 213 dividend equivalent units at a reference price of $70.47 per unit, tied to restricted stock units in Synchrony common stock. Following this, the officer beneficially owned 57,130 shares of common stock directly.

The filing also shows acquisition of 0.78 phantom stock units under the Synchrony Financial Deferred Compensation Plan, increasing total phantom stock units beneficially owned to 184.13. Both the dividend equivalent units and phantom stock units are described as economically equivalent to shares of Synchrony common stock, with the phantom units to be settled in cash six months after the officer’s separation from service, in line with plan terms.

Rhea-AI Summary

Synchrony Financial director reports small increase in equity holdings. A company director of Synchrony Financial (SYF) filed a Form 4 detailing an automatic accrual of dividend equivalent units on November 17, 2025. The filing shows the acquisition of 15 dividend equivalent units at a reference price of $70.47 per unit, linked to previously granted restricted stock units. After this transaction, the reporting person beneficially owns 15,558 SYF shares or equivalents in direct ownership. These dividend equivalent units are economically equal to shares of common stock and will vest and settle on the same schedule and terms as the related restricted stock units.

Rhea-AI Summary

Synchrony Financial director reported a routine equity-related transaction involving dividend equivalent units tied to restricted stock units. On November 17, 2025, the reporting person accrued 15 dividend equivalent units based on dividends paid on the common shares underlying existing restricted stock units at a referenced value of $70.47 per unit. Each unit is the economic equivalent of one share of Synchrony Financial common stock and will vest, settle, and expire on the same terms as the related restricted stock units.

Following this accrual, the reporting person beneficially owned 27,902 shares of Synchrony Financial common stock directly and 15,300 shares indirectly through family trusts. This reflects ongoing alignment of the director’s interests with shareholders through equity-based compensation rather than a discretionary open-market trade.

Rhea-AI Summary

Synchrony Financial director Form 4 shows a small equity accrual. A company director reported acquiring 15 dividend equivalent units on 11/17/2025 at a price of $70.47 per unit. These units were credited as dividends on common shares underlying existing restricted stock units.

Following this transaction, the reporting person beneficially owns 29,869 Synchrony Financial common shares on a direct basis. Each dividend equivalent unit is the economic equivalent of one common share and will vest and settle on the same schedule and terms as the related restricted stock units.

Rhea-AI Summary

Synchrony Financial (SYF) reported an insider equity accrual, as an executive officer acquired 213 dividend equivalent units on 11/17/2025 tied to existing restricted stock units. These units reflect dividends paid on the common shares underlying those awards and are economically equivalent to one share of Synchrony common stock each.

After this transaction, the reporting executive directly beneficially owned 108,484 common shares. The dividend equivalent units will vest and settle on the same schedule and terms as the related restricted stock units. The officer’s title is listed as EVP, CEO--Home & Auto.

Rhea-AI Summary

Synchrony Financial (SYF) reported a routine insider update for one of its directors. On 11/17/2025, the director acquired 130 dividend equivalent units at $70.47 each. These units were accrued as dividends on the common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan. After this transaction, the director beneficially owned 49,095 Synchrony Financial common shares in total.

Rhea-AI Summary

Synchrony Financial (SYF) reported a small change in insider holdings for an executive. On November 17, 2025, an officer received 249 dividend equivalent units tied to previously granted restricted stock units. These units were valued at $70.47 each and are designed to mirror dividends paid on the underlying common shares.

After this transaction, the officer beneficially owns 58,530 Synchrony Financial common shares directly. The dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units and are economically equal to one share of common stock each. The reporting person serves as EVP, Chief Technology and Operating Officer of Synchrony Financial.

Rhea-AI Summary

A director of Synchrony Financial (SYF) reported the automatic accrual of 15 dividend equivalent units on November 17, 2025. These units were credited as dividends paid on the common shares underlying the director’s restricted stock units. Each dividend equivalent unit is described as the economic equivalent of one share of Synchrony Financial common stock and will vest and settle on the same terms and schedule as the related restricted stock units.

Following this transaction, the director beneficially owns 3,312 Synchrony Financial common shares in direct form. The filing is a routine Form 4 disclosure of equity-based compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Synchrony Financial EVP reports multiple stock transactions. An executive officer of Synchrony Financial (SYF), serving as EVP, Chief Risk and Legal Officer, reported several transactions dated 11/17/2025. These included 238 dividend equivalent units acquired at $70.47, which mirror restricted stock units, and the sale of 20,000 shares of common stock at $72.80 under a Rule 10b5-1 trading plan adopted on July 28, 2025. The executive also exercised 12,000 employee stock options at $34.30 per share and sold 12,000 shares of common stock at $72.80 on the same date. Following these transactions, the executive directly beneficially owns 127,100 shares of Synchrony Financial common stock and 11,258 employee stock options.

Rhea-AI Summary

Synchrony Financial director Form 4 filing reports that a board member received 148 dividend equivalent units of Synchrony Financial common stock on November 17, 2025. These units were accrued as dividends on common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan.

Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the reporting person holds 38,074 shares of common stock directly and 34,106 shares indirectly through Guthrie 2012 Investments LP, for which he is investment manager and disclaims beneficial ownership except for his direct pecuniary interest.

Rhea-AI Summary

Synchrony Financial director reports automatic dividend share equivalents

A director of Synchrony Financial (SYF) reported an automatic accrual of dividend equivalent units on common stock. On November 17, 2025, the reporting person acquired 190 dividend equivalent units at a value of $70.47 per unit. These units relate to dividends paid on common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the reporting person beneficially owned 61,452 common share equivalents, held in a direct capacity.